These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 17722019)

  • 21. Preventing restenosis with stent drug coatings.
    Belardi J
    J Invasive Cardiol; 2002 Sep; 14(9):576-82. PubMed ID: 12369563
    [No Abstract]   [Full Text] [Related]  

  • 22. Value and limitations of target-vessel ischemia in predicting late clinical events after drug-eluting stent implantation.
    Zellweger MJ; Kaiser C; Brunner-La Rocca HP; Buser PT; Osswald S; Weiss P; Mueller-Brand J; Pfisterer ME;
    J Nucl Med; 2008 Apr; 49(4):550-6. PubMed ID: 18344439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mycophenolic acid-eluting stent and the ABC's of stent-based immunosuppressive therapies for the prevention of restenosis.
    Carter AJ
    Catheter Cardiovasc Interv; 2005 Dec; 66(4):496-8. PubMed ID: 16283681
    [No Abstract]   [Full Text] [Related]  

  • 24. The future of drug eluting stents.
    Anis RR; Karsch KR
    Heart; 2006 May; 92(5):585-8. PubMed ID: 16216857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Covered stents: a review.
    Jamshidi P; Mahmoody K; Erne P
    Int J Cardiol; 2008 Nov; 130(3):310-8. PubMed ID: 18672301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. First successful implantation of a biodegradable metal stent into the left pulmonary artery of a preterm baby.
    Zartner P; Cesnjevar R; Singer H; Weyand M
    Catheter Cardiovasc Interv; 2005 Dec; 66(4):590-4. PubMed ID: 16206223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of drug-eluting stent implantation for patients with unprotected left main coronary artery stenosis.
    Kim YH; Dangas GD; Solinas E; Aoki J; Parise H; Kimura M; Franklin-Bond T; Dasgupta NK; Kirtane AJ; Moussa I; Lansky AJ; Collins M; Stone GW; Leon MB; Moses JW; Mehran R
    Am J Cardiol; 2008 Mar; 101(6):801-6. PubMed ID: 18328844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bioabsorbable stenting for peripheral arterial occlusive disease.
    Geraghty PJ
    Perspect Vasc Surg Endovasc Ther; 2006 Dec; 18(4):295-8. PubMed ID: 17351191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Nude stents, coated stents].
    Puel J
    Bull Acad Natl Med; 2005 Feb; 189(2):237-47. PubMed ID: 16114855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents.
    Caixeta A; Leon MB; Lansky AJ; Nikolsky E; Aoki J; Moses JW; Schofer J; Morice MC; Schampaert E; Kirtane AJ; Popma JJ; Parise H; Fahy M; Mehran R
    J Am Coll Cardiol; 2009 Sep; 54(10):894-902. PubMed ID: 19712798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioabsorbable and biocompatible stents. Is a new revolution coming?
    Rogacka R; Chieffo A; Latib A; Colombo A
    Minerva Cardioangiol; 2008 Oct; 56(5):483-91. PubMed ID: 18813184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Designer stents and restenosis.
    Vetrovec GW
    Catheter Cardiovasc Interv; 2003 Oct; 60(2):179. PubMed ID: 14517921
    [No Abstract]   [Full Text] [Related]  

  • 33. A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale.
    Ribichini F; Tomai F; De Luca G; Boccuzzi G; Presbitero P; Pesarini G; Ferrero V; Ghini AS; Pastori F; De Luca L; Zavalloni D; Soregaroli D; Garbo R; Franchi E; Marino P; Minelli M; Vassanelli C
    J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):192-9. PubMed ID: 19377384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Very late drug-eluting stent thrombosis and cardiogenic shock: 1,249 days after implantation.
    Chen JP
    J Invasive Cardiol; 2007 Dec; 19(12):E381-4. PubMed ID: 18180534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rates of stent thrombosis in bare-metal versus drug-eluting stents (from a large Australian multicenter registry).
    Yan BP; Duffy SJ; Clark DJ; Lefkovits J; Warren R; Gurvitch R; Lew R; Sebastian M; Brennan A; Andrianopoulos N; Reid CM; Ajani AE;
    Am J Cardiol; 2008 Jun; 101(12):1716-22. PubMed ID: 18549846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Passive and active polymer coatings for intracoronary stents: novel devices to promote arterial healing.
    Pendyala L; Jabara R; Robinson K; Chronos N
    J Interv Cardiol; 2009 Feb; 22(1):37-48. PubMed ID: 19281521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Coronary stents. From a simple idea to a medical high-tech device].
    Wieneke H; Böse D; Haude M; Eggebrecht H; Konorza T; Naber C; Erbel R
    Med Klin (Munich); 2005 Aug; 100(8):505-11. PubMed ID: 16096733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Newer stents: looking at the horizon.
    Ramcharitar S; Serruys PW
    Indian Heart J; 2007; 59(2 Suppl B):B59-71. PubMed ID: 19153438
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Survey of coronary stents development for restenosis prevention].
    Chen J; Ni Z; Gu X
    Zhongguo Yi Liao Qi Xie Za Zhi; 2009 Nov; 33(6):429-34. PubMed ID: 20352916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel drug-eluting stent using bioabsorbable polymer technology: two-year follow-up of the CURAMI registry.
    Tin Hay E; Hou XM; Lim J; Low A; Teo SG; Tan HC; Lee CH
    Int J Cardiol; 2009 Jan; 131(2):272-4. PubMed ID: 17942172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.